[Our experience with pediatric pH-metry]

Related Experiment Videos

F Valente1, A Ginardi, O Paino

  • 1Divisione di Chirurgia Generale, Regione Piemonte, Azienda Regionale USL n. 9, Ospedale Civile di Ivrea, Torino.

Minerva Chirurgica
|March 7, 1998
PubMed

Insights

Pediatric pH monitoring is a safe and effective test for diagnosing gastrointestinal issues in children. This diagnostic tool aids in identifying and treating various conditions, improving patient outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Diagnostic Medicine

Context:

  • Gastroesophageal reflux disease (GERD) and related symptoms in children can be challenging to diagnose.
  • Accurate diagnostic tools are essential for appropriate management.

Purpose:

  • To evaluate the utility and tolerability of pH monitoring in pediatric patients.
  • To assess the role of pH monitoring in diagnosing various gastrointestinal conditions in children.

Summary:

  • The study involved pH monitoring in pediatric patients with symptoms such as heartburn, vomiting, or cough, and those with endoscopic findings of cardia incompetence or esophagitis.
  • Patients were selected based on specific clinical and endoscopic criteria.
  • The authors present their experience and findings, comparing them with existing literature.

Impact:

  • pH monitoring is a well-tolerated and easily performed diagnostic test in children.
  • The test provides valuable insights for diagnosing and managing pediatric gastrointestinal pathologies.
  • Accurate diagnosis leads to appropriate treatment and improved clinical results.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...